# Study of the Experience of Patients With Osteoporosis Using the Forteo B Pen to Self Administer Once Daily Teriparatide Therapy

> **NCT00577863** · PHASE3 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 200 (actual)

## Conditions studied

- Osteoporosis

## Interventions

- **DRUG:** teriparatide

## Key facts

- **NCT ID:** NCT00577863
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-01
- **Primary completion:** 2008-05
- **Final completion:** 2008-12
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2009-07-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00577863

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00577863, "Study of the Experience of Patients With Osteoporosis Using the Forteo B Pen to Self Administer Once Daily Teriparatide Therapy". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00577863. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*